Update on our digital platform for gene therapy

Gene: a platform for gene therapy

The weekend in Frankfurt am Main was the culmination of nearly 2.5 years of hard work and dedication. Our platform smart medication Gene went live right on time for the 1st Gentherapie-DIALOG 2023.

The launch of our gene therapy platform marked a significant milestone. This platform enables healthcare professionals to effectively document their patients’ gene therapy. In developing the user experience (UX), the focus was on maximum intuitiveness and ease of use.

A bridge between yesterday and tomorrow

The historic walls of the Senckenberg Museum served as the backdrop for a congress that merged past and present. Over the centuries, Senckenberg researchers have shaped our understanding of evolution and biodiversity. Today, science is dedicated to this innovative approach to treating hemophilia.

Focus on the patient

Gene therapy has the potential to change many things. GENE provides support not only in hemophilia but also in the field of gene therapies in general. The vision is clear: the focus is on the patient, not on bureaucracy.

Thanks to BioMarin and CSL Behring, physicians, patients, hemophilia nurses, pharmacists, and everyone who contributed to the development.